Assessment
Questionnaire

Have a symptom?
See what questions
a doctor would ask.
 

Statistics about Colorectal cancer

Prevalence and incidence statistics for Colorectal cancer:

See also prevalence and incidence page for Colorectal cancer

Incidence (annual) of Colorectal cancer: 148,300 annual cases = 107,300 annual cases of colon cancer and 41,000 annual cases of rectum cancer(SEER 2002 estimate)

Incidence Rate: approx 1 in 1,834 or 0.05% or 148,300 people in USA [about data]

Incidence extrapolations for USA for Colorectal cancer: 148,300 per year, 12,358 per month, 2,851 per week, 406 per day, 16 per hour, 0 per minute, 0 per second. Note: this extrapolation calculation uses the incidence statistic: 148,300 annual cases = 107,300 annual cases of colon cancer and 41,000 annual cases of rectum cancer(SEER 2002 estimate)

Lifetime risk for Colorectal cancer: 1 in 26 women and 1 in 17 men will develop colorectal cancer during their lifetime in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)

Prevalance of Colorectal cancer: The American Cancer Society estimates that there will be 93,800 new cases of colon cancer diagnosed in the US in 2000, with 47,700 resulting deaths. (Source: Genes and Disease by the National Center for Biotechnology)

Prevelance statistics about Colorectal cancer:

The following statistics relate to the prevalence of Colorectal cancer:

  • 12,000 women in the UK 2001 (National Statistics - UK Government Census, 2001)
  • 14,800 men in the UK 2001 (National Statistics - UK Government Census, 2001)
  • 1 in 26 women will develop colorectal cancer during their lifetime in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
  • 1 in 17 men will develop colorectal cancer in their lifetime in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
  • more about prevalence...»

Incidence statistics about Colorectal cancer:

The following statistics relate to the incidence of Colorectal cancer:

  • 106,370 new cases for colon cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 50,400 new male cases for colon cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 55,970 new female cases for colon cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 57,000 new cases in women in the US 2002 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 40,570 new cases for rectum cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 23,220 new male cases for rectum cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 17,350 new female cases for rectum cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 44.2 new black male cases of colorectal cancer occurred per 100,000 population in the USA 1993-97 (Parkin et al 2002, Australia’s Health 2004, AIHW)
  • 38.1 new white male cases of colorectal cancer occurred per 100,000 population in the USA 1993-97 (Parkin et al 2002, Australia’s Health 2004, AIHW)
  • 34.3 new black female cases of colorectal cancer occurred per 100,000 population in the USA 1993-97 (Parkin et al 2002, Australia’s Health 2004, AIHW)
  • 27.6 new white female cases of colorectal cancer occurred per 100,000 population in the USA 1993-97 (Parkin et al 2002, Australia’s Health 2004, AIHW)
  • Colon and rectal cancer incidence statistics by race and gender subgroups in the USA:
    • 64.1 white men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 72.4 African American men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 57.2 Asian American and Pacific Islander men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 37.5 American Indian and Alaska Native men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 49.8 Hispanic Latino men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 46.2 white women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 56.2 African American women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 38.8 Asian American and Pacific Islander women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 32.6 American Indian and Alaska Native women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 32.9 Hispanic Latino women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
  • Colorectal cancer incidence statistics for women in various countries:
    • 55 men per 100,000 population with colorectal cancer in the Czech Republic 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 41.8 men per 100,000 population with colorectal cancer in Canada 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 38.9 men per 100,000 population with colorectal cancer in the US 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 38.5 men per 100,000 population with colorectal cancer in China 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 38.3 men per 100,000 population with colorectal cancer in Denmark 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 37.6 men per 100,000 population with colorectal cancer in Singapore 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 35.8 men per 100,000 population with colorectal cancer in Japan 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 35.4 men per 100,000 population with colorectal cancer in the UK 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 30.3 men per 100,000 population with colorectal cancer in Sweden 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 29.4 men per 100,000 population with colorectal cancer in Poland 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 12.2 men per 100,000 population with colorectal cancer in Colombia 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 6.7 men per 100,000 population with colorectal cancer in India 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
  • Colorectal cancer incidence statistics for women in various countries:
    • 29.8 women per 100,000 population with colorectal cancer in Czech Republic 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 29.7 women per 100,000 population with colorectal cancer in Denmark 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 29.3 women per 100,000 population with colorectal cancer in Sigapore 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 28.8 women per 100,000 population with colorectal cancer in Canada 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 28.3 women per 100,000 population with colorectal cancer in China 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 28.0 women per 100,000 population with colorectal cancer in the US 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 23.2 women per 100,000 population with colorectal cancer in Sweden 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 22.8 women per 100,000 population with colorectal cancer in the UK 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 20.9 women per 100,000 population with colorectal cancer in Japan 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 19.5 women per 100,000 population with colorectal cancer in Poland 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 14.0 women per 100,000 population with colorectal cancer in Colombia 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
    • 5.5 women per 100,000 population with colorectal cancer in India 1993-97 (Surveillance and Risk Assessment Division, CCDP, Health Canada)
  • 8,800 new cases of colorectal cancer in women in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • 62 per 100,000 new cases of colorectal cancer in men in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • 41 per 100,000 new cases of colorectal cancer in women in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • 10,400 new cases of colorectal cancer in men in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • 54 new female cases of colorectal cancer per 100,000 population in Australia 2000 (Australia’s Health 2004, AIHW)
  • 80 new male cases of colorectal cancer per 100,000 population in Australia 2000 (Australia’s Health 2004, AIHW)
  • Incidence statistics by state in Australia for males:
    • 76.9 new male cases of colorectal cancer occurred per 100,000 population in New South Wales 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
    • 79.9 new male cases of colorectal cancer occurred per 100,000 population in Victoria 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
    • 78.9 new male cases of colorectal cancer occurred per 100,000 population in Queensland 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
    • 76.8 new male cases of colorectal cancer occurred per 100,000 population in Western Australia 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
    • 79.1 new male cases of colorectal cancer occurred per 100,000 population in South Australia 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
    • 74.6 new male cases of colorectal cancer occurred per 100,000 population in Tasmania 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
    • 75.5 new male cases of colorectal cancer occurred per 100,000 population in Australian Capital Territory 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
    • 54.7 new male cases of colorectal cancer occurred per 100,000 population in Northern Territory 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
  • Incidence statistics by state in Australia for females:
    • 51.9 new female cases of colorectal cancer occurred per 100,000 population in New South Wales 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
    • 54.7 new female cases of colorectal cancer occurred per 100,000 population in Victoria 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
    • 56.7 new female cases of colorectal cancer occurred per 100,000 population in Queensland 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
    • 49.4 new female cases of colorectal cancer occurred per 100,000 population in Western Australia 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
    • 56.6 new female cases of colorectal cancer occurred per 100,000 population in South Australia 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
    • 58.7 new female cases of colorectal cancer occurred per 100,000 population in Tasmania 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
    • 52.2 new female cases of colorectal cancer occurred per 100,000 population in Australian Capital Territory 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
    • 42.2 new female cases of colorectal cancer occurred per 100,000 population in Northern Territory 2000 (AIHW & AACR 2003, Australia’s Health 2004, AIHW)
  • Incidence statistics for various countries:
    • 41.8 new male cases of colorectal cancer occurred per 100,000 population in Canada 1993-97 (Parkin et al 2002, Australia’s Health 2004, AIHW)
    • 35.5 new male cases of colorectal cancer occurred per 100,000 population in UK, England 1993-97 (Parkin et al 2002, Australia’s Health 2004, AIHW)
    • 39.9 new male cases of colorectal cancer occurred per 100,000 population in Italy, Venetian Region 1993-96 (Parkin et al 2002, Australia’s Health 2004, AIHW)
    • 35.8 new male cases of colorectal cancer occurred per 100,000 population in Japan, Osaka Prefecture 1993-97 (Parkin et al 2002, Australia’s Health 2004, AIHW)
    • 38.1 new male cases of colorectal cancer occurred per 100,000 population in The Netherlands 1993-97 (Parkin et al 2002, Australia’s Health 2004, AIHW)
    • 52 new male cases of colorectal cancer occurred per 100,000 population in New Zealand 1993-97 (Parkin et al 2002, Australia’s Health 2004, AIHW)
    • 28.8 new female cases of colorectal cancer occurred per 100,000 population in Canada 1993-97 (Parkin et al 2002, Australia’s Health 2004, AIHW)
    • 22.8 new female cases of colorectal cancer occurred per 100,000 population in UK, England 1993-97 (Parkin et al 2002, Australia’s Health 2004, AIHW)
    • 24.8 new female cases of colorectal cancer occurred per 100,000 population in Italy, Venetian Region 1993-96 (Parkin et al 2002, Australia’s Health 2004, AIHW)
    • 20.9 new female cases of colorectal cancer occurred per 100,000 population in Japan, Osaka Prefecture 1993-97 (Parkin et al 2002, Australia’s Health 2004, AIHW)
    • 28.0 new female cases of colorectal cancer occurred per 100,000 population in The Netherlands 1993-97 (Parkin et al 2002, Australia’s Health 2004, AIHW)
    • 40.6 new female cases of colorectal cancer occurred per 100,000 population in New Zealand 1993-97 (Parkin et al 2002, Australia’s Health 2004, AIHW)
  • 5,542 new cases of colorectal cancer occurred in women in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
  • Colorectal cancer accounted for 14.1% of all new cases of female cancer in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
  • 53.8 new female cases of colorectal cancer per 100,000 population in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
  • 6,863 new male cases of colorectal cancer occurred in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
  • Colorectal cancer accounted for 14.9% of all new cases of male cancer in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
  • 80.2 new cases of colorectal cancer per 100,000 population occurred in men in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
  • more about incidence...»

Death and mortality statistics for Colorectal cancer:

Deaths from Colorectal cancer: 57,200 deaths in USA 1999 (CDC)

Death rate extrapolations for USA for Colorectal cancer: 57,199 per year, 4,766 per month, 1,099 per week, 156 per day, 6 per hour, 0 per minute, 0 per second. Note: this extrapolation calculation uses the deaths statistic: 57,200 deaths in USA 1999 (CDC)

Death statistics for Colorectal cancer:

The following are statistics from various sources about deaths and Colorectal cancer:

  • 57,155 deaths reported in USA 1999 (NVSR Sep 2001)
  • 56,730 estimated deaths for colon cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 28,320 estimated male deaths for colon cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 28,410 estimated female deaths for colon cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • Third leading cause of cancer deaths in women in the US (Cancer Facts and Figures, American Cancer Society, 2004)
  • 28,800 deaths in women in the US 2002 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 16.4 per 100,000 population of white Americans 1996 (CBCF Health Organisation, 2004)
  • 22.5 per 100,000 population of black Americans 1996 (CBCF Health Organisation, 2004)
  • 55.3 per 100,000 people in USA 2001 (NCHS, 2003)
  • 24.2 per 100,000 men died from colorectal cancer in USA 2001 (NCHS, 2003)
  • 17.2 per 100,000 women died from colorectal cancer in USA 2001 (NCHS, 2003)
  • Colorectal cancer death statistics by racial group in the USA:
    • 25.3 white men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 34.6 African American men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 15.8 Asian American and Pacific Islander men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 18.5 American Indian and Alaska Native men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 18.4 Hispanic Latino men per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 17.5 white women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 24.6 African American women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 11.0 Asian American and Pacific Islander women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 12.1 American Indian and Alaska Native women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 11.4 Hispanic Latino women per 100,000 in the US 1996-2000 (SEER Cancer Statistics Review, National Cancer Institute, 1975-2000)
    • 11.6 per 100,000 Asian/Pacific Islander people died from colorectal cancer in USA 2001 (NCHS, 2003)
    • 12.0 per 100,000 American Indian or Alaska Native people died from colorectal cancer in USA 2001 (NCHS, 2003)
    • 14.1 per 100,000 Hispanic/Latino people died from colorectal cancer in USA 2001 (NCHS, 2003)
    • 19.6 per 100,000 white people died from colorectal cancer in USA 2001 (NCHS, 2003)
    • 27.6 per 100,000 black people died from colorectal cancer in USA 2001 (NCHS, 2003)
  • 4,500 deaths in men from colorectal cancer in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • 3,900 deaths in women from colorectal cancer in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • 27 per 100,000 deaths in men from colorectal cancer in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • 17 per 100,000 deaths in women from colorectal cancer in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • Mortality rates for colorectal cancer deaths in various countries:
    • 15.9 men per 100,000 population in the US 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 12.0 women per 100,000 population in the US 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 20.1 men per 100,000 population in Australia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 14.4 women per 100,000 population in Australia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 23.0 men per 100,000 population in Austria 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 14.9women per 100,000 population in Austria 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 6.4 men per 100,000 population in Azerbaijan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.8 women per 100,000 population in Azerbaijan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 17.8 men per 100,000 population in Bulgaria 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 12.0 women per 100,000 population in Bulgaria 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 16.4 men per 100,000 population in Canada 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 11.6 women per 100,000 population in Canada 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 7.0 men per 100,000 population in Chile 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 7.1 women per 100,000 population in Chile 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 7.2 men per 100,000 population in China 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 5.3 women per 100,000 population in China 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 5.8 men per 100,000 population in Colombia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 6.1 women per 100,000 population in Colombia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 24.8 men per 100,000 population in Croatia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 13.0 women per 100,000 population in Croatia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 11.4 men per 100,000 population in Cuba 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 12.4 women per 100,000 population in Cuba 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 34.2 men per 100,000 population in Czech Republic 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 18.5 women per 100,000 population in Czech Republic 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 23.8 men per 100,000 population in Denmark 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 18.5 women per 100,000 population in Denmark 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 16.7 men per 100,000 population in Estonia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 12.0 women per 100,000 population in Estonia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 12.5 men per 100,000 population in Finland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 9.5 women per 100,000 population in Finland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 18.3men per 100,000 population in France 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 12.1 women per 100,000 population in France 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 21.7 men per 100,000 population in Germany 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 17.0 women per 100,000 population in Germany 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 8.4 men per 100,000 population in Greece 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 6.7 women per 100,000 population in Greece 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 33.5 men per 100,000 population in Hungary 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 20.9 women per 100,000 population in Hungary 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 22.6 men per 100,000 population in Ireland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 15.4 women per 100,000 population in Ireland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 19.7 men per 100,000 population in Israel 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 15.3 women per 100,000 population in Israel 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 17.6 men per 100,000 population in Japan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 11.0 women per 100,000 population in Japan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 12.2 men per 100,000 population in Kazakhstan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 8.6 women per 100,000 population in Kazakhstan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 10.9 men per 100,000 population in Kyrgyzstan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 7.7 women per 100,000 population per 100,000 population in Kyrgyzstan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 17.9 men per 100,000 population in Latvia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000196.7 American Cancer Society)
    • 13.3 women per 100,000 population in Latvia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 18.0 men per 100,000 population in Lithuania 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 10.7 women per 100,000 population in Lithuania 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 11.2 men per 100,000 population in Macedonia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 7.8 women per 100,000 population in Macedonia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 5.8 men per 100,000 population in Mauritius 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 3.9 women per 100,000 population in Mauritius 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.7 men per 100,000 population in Mexico 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.6 women per 100,000 population in Mexico 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 19.0 men per 100,000 population in the Netherlands 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 14.0 women per 100,000 population in the Netherlands 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 25.7 men per 100,000 population in New Zealand 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 20.2 women per 100,000 population in New Zealand 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 22.0 men per 100,000 population in Norway 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 18.0 women per 100,000 population in Norway 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 16.6 men per 100,000 population in Poland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 11.6 women per 100,000 population in Poland 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 18.5 men per 100,000 population in Portugal 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 11.3 women per 100,000 population in Portugal 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 15.9 men per 100,000 population in Republic of Moldova 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 10.6 women per 100,000 population in Republic of Moldova 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 11.4 men per 100,000 population in Romania 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 8.2 women per 100,000 population in Romania 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 17.5 men per 100,000 population in the Russian Federation 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 12.7 women per 100,000 population in the Russian Federation 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 9.5 men per 100,000 population in Slovakia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 28.0 women per 100,000 population in Slovakia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 16.1 men per 100,000 population in Slovenia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 25.1 women per 100,000 population in Slovenia 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 17.3 men per 100,000 population in Spain 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 11.1 women per 100,000 population in Spain 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 14.4 men per 100,000 population in Sweden 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 11.5 women per 100,000 population in Sweden 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 8.5 men per 100,000 population in Trinidad and Tobago 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 9.7 women per 100,000 population in Trinidad and Tobago 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.7 men per 100,000 population in Turkmenistan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 4.1 women per 100,000 population in Turkmenistan 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 18.7 men per 100,000 population in the UK 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 13.8 women per 100,000 population in the UK 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 5.8 men per 100,000 population in Venezuela 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
    • 6.1 women per 100,000 population in Venezuela 2000 (Cancer Incidence, Mortality, and Prevalence Worldwide, GLOBOCAN, 2000 American Cancer Society)
  • 2,201 women died from colorectal cancer in Australia 2002 (AIHW National Morbidity Database, Australia’s Health 2004, AIHW)
  • 2,448 men died from colorectal cancer in Australia 2002 (AIHW National Morbidity Database, Australia’s Health 2004, AIHW)
  • 20 women per 100,000 population die of colorectal cancer in Australia 2002 (Australia’s Health 2004, AIHW)
  • 28 men per 100,000 population die of colorectal cancer in Australia 2002 (Australia’s Health 2004, AIHW)
  • 3.4% of all female deaths was due colorectal cancer to in Australia 2002 (AIHW National Morbidity Database, Australia’s Health 2004, AIHW)
  • 3.6% of all male deaths was due to colorectal cancer in Australia 2002 (AIHW National Morbidity Database, Australia’s Health 2004, AIHW)
  • Death statistics by state in Australia:
    • Colorectal cancer caused 31.2 male deaths per 100,000 population in New South Wales 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Colorectal cancer caused 34.8 male deaths per 100,000 population in Victoria 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Colorectal cancer caused 33.4 male deaths per 100,000 population in Queensland 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Colorectal cancer caused 35.1 male deaths per 100,000 population in Western Australia 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Colorectal cancer caused 34.7 male deaths per 100,000 population in South Australia 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Colorectal cancer caused 35.4 male deaths per 100,000 population in Tasmania 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Colorectal cancer caused 33.7 male deaths per 100,000 population in Australian Capital Territory 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Colorectal cancer caused 17.7 male deaths per 100,000 population in Northern Territory 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Colorectal cancer caused 20.6 female deaths per 100,000 population in New South Wales 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Colorectal cancer caused 23.2 female deaths per 100,000 population in Victoria 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Colorectal cancer caused 23 female deaths per 100,000 population in Queensland 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Colorectal cancer caused 21.9 female deaths per 100,000 population in Western Australia 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Colorectal cancer caused 22.3 female deaths per 100,000 population in South Australia 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Colorectal cancer caused 31.4 female deaths per 100,000 population in Tasmania 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Colorectal cancer caused 24.7 female deaths per 100,000 population in Australian Capital Territory 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
    • Colorectal cancer caused 15.7 female deaths per 100,000 population in Northern Territory 2000-2002 (AIHW National Mortality Database, Australia’s Health 2004)
  • Colorectal cancer caused 2,149 female deaths in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
  • Colorectal cancer accounted for 13.9% of female cancer deaths in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
  • Colorectal cancer accounted for 20.2 female deaths per 100,000 population in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
  • Colorectal cancer caused 2,569 male deaths in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
  • Colorectal cancer accounted for 12.8% of male cancer deaths in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
  • 31 deaths from colorectal cancer per 100,000 population occurred in men in Australia 2000 (AIHW and AACR, AIHW National Mortality Database, Australia’s Health 2004, AIHW)
  • more about deaths...»

Survival Rate & Life Expectancy for Colorectal cancer

Survival rate for Colorectal cancer: 47% survival rate for colon cancer in the UK 2001 (National Statistics – UK Government Census, 2001)

Survival rate statistics for Colorectal cancer:

The following are statistics from various sources about the survival rate for Colorectal cancer:

  • 59.2% of people with colon and rectal cancer survive after 5 years in the US 1983-90 (SEER)
  • 63% of white people survive 5 years for colon cancer in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 53% of African American people survive 5 years for colon cancer in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 62% survive 5 years for colon cancer in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 62% of white people survive 5 years for rectal cancer in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 53% of African American people survive 5 years for rectal cancer in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 62% survive 5 years for rectal cancer in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 5-year survival rate for black people with colon and rectal cancer is 49.5% in the US 1983-90 (SEER)
  • 5-year survival rate for people with colon and rectal cancer is 59.2% in the US 1983-90 (SEER)
  • 5-year survival rate for white people with colon and rectal cancer is 60.1% in the US 1983-90 (SEER)
  • 1-year survival rate for men aged 15-99 with colon cancer is 64.1% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 15-99 with colon cancer is 42.1% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 15-39 with colon cancer is 79% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 15-39 with colon cancer is 56% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 40-49 with colon cancer is 75% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 40-49 with colon cancer is 49% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 50-59 with colon cancer is 73% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 50-59 with colon cancer is 46% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 60-69 with colon cancer is 69% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 60-69 with colon cancer is 44% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 70-79 with colon cancer is 63% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 70-79 with colon cancer is 42% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 80-99 with colon cancer is 53% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 80-99 with colon cancer is 36% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 15-99 with colon cancer is 63.3% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 15-99 with colon cancer is 42.8% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 15-39 with colon cancer is 78% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 15-39 with colon cancer is 59% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 40-49 with colon cancer is 78% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 40-49 with colon cancer is 49% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 50-59 with colon cancer is 75% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 50-59 with colon cancer is 47% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 60-69 with colon cancer is 70% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 60-69 with colon cancer is 46% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 70-79 with colon cancer is 63% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 70-79 with colon cancer is 43% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 80-99 with colon cancer is 48% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 80-99 with colon cancer is 34% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 15-99 with rectum cancer is 69% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 15-99 with rectum cancer is 40.3% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 15-39 with rectum cancer is 79% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 15-39 with rectum cancer is 51% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 40-49 with rectum cancer is 80% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 40-49 with rectum cancer is 46% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 50-59 with rectum cancer is 78% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 50-59 with rectum cancer is 45% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 60-69 with rectum cancer is 74% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 60-69 with rectum cancer is 43% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 70-79 with rectum cancer is 67% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 70-79 with rectum cancer is 40% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 80-99 with rectum cancer is 56% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 80-99 with rectum cancer is 33% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 15-99 with rectum cancer is 71.4% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 15-99 with rectum cancer is 44.8% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 15-39 with rectum cancer is 87% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 15-39 with rectum cancer is 56% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 40-49 with rectum cancer is 81% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 40-49 with rectum cancer is 53% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 50-59 with rectum cancer is 82% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 50-59 with rectum cancer is 52% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 60-69 with rectum cancer is 78% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 60-69 with rectum cancer is 49% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 70-79 with rectum cancer is 70% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 70-79 with rectum cancer is 44% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 80-99 with rectum cancer is 54% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 80-99 with rectum cancer is 33% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 7 months is the median survival for patients with advanced colorectal cancer at time of diagnosis (Cancer, Vol 2, No. 8: 2211-2219, American Cancer Society)
  • 16 months is the median survival for patients with advanced colorectal who are still alive two years after diagnosis (Cancer, Vol 2, No. 8: 2211-2219, American Cancer Society)
  • Nearly 6 years is the median survival for patients with advanced colorectal who are still alive five years after diagnosis (Cancer, Vol 2, No. 8: 2211-2219, American Cancer Society)
  • more about deaths...»

Life Expectancy & Years of Life Lost for Colorectal cancer

Average life years lost for Colorectal cancer: 13.4 years for colon/rectum cancer (SEER)1

Society statistics for Colorectal cancer

Hospitalization statistics for Colorectal cancer:

The following are statistics from various sources about hospitalizations and Colorectal cancer:

  • 0.75% (95,420) of hospital consultant episodes were for malignant neoplasm of colon in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 92% of hospital consultant episodes for malignant neoplasm of colon required hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 55% of hospital consultant episodes for malignant neoplasm of colon were for men in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 45% of hospital consultant episodes for malignant neoplasm of colon were for women in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 10% of hospital consultant episodes for malignant neoplasm of colon required emergency hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 12.6 days was the mean length of stay in hospitals for malignant neoplasm of colon in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 9 days was the median length of stay in hospitals for malignant neoplasm of colon in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 66 was the mean age of patients hospitalised for malignant neoplasm of colon in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 26% of hospital consultant episodes for malignant neoplasm of colon occurred in 15-59 year olds in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 25% of hospital consultant episodes for malignant neoplasm of colon occurred in people over 75 in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 64% of hospital consultant episodes for malignant neoplasm of colon were single day episodes in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 0.65% (339,110) of hospital bed days were for malignant neoplasm of colon in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 0.12% (15,719) of hospital consultant episodes were for malignant neoplasm of rectosigmoid junction in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 94% of hospital consultant episodes for malignant neoplasm of rectosigmoid junction required hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 65% of hospital consultant episodes for malignant neoplasm of rectosigmoid junction were for men in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 35% of hospital consultant episodes for malignant neoplasm of rectosigmoid junction were for women in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 7% of hospital consultant episodes for malignant neoplasm of rectosigmoid junction required emergency hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 12.8 days was the mean length of stay in hospitals for malignant neoplasm of rectosigmoid junction in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 10 days was the median length of stay in hospitals for malignant neoplasm of rectosigmoid junction in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 65 was the mean age of patients hospitalised for malignant neoplasm of rectosigmoid junction in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 28% of hospital consultant episodes for malignant neoplasm of rectosigmoid junction occurred in 15-59 year olds in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 20% of hospital consultant episodes for malignant neoplasm of rectosigmoid junction occurred in people over 75 in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • % of hospital consultant episodes for malignant neoplasm of rectosigmoid jun70ction were single day episodes in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 0.09% (47,458) of hospital bed days were for malignant neoplasm of rectosigmoid junction in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 0.39% (49,530) of hospital consultant episodes were for malignant neoplasm of rectum in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 94% of hospital consultant episodes for malignant neoplasm of rectum required hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 65% of hospital consultant episodes for malignant neoplasm of rectum were for men in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 35% of hospital consultant episodes for malignant neoplasm of rectum were for women in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 7% of hospital consultant episodes for malignant neoplasm of rectum required emergency hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 12.2 days was the mean length of stay in hospitals for malignant neoplasm of rectum in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 9 days was the median length of stay in hospitals for malignant neoplasm of rectum in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 65 was the mean age of patients hospitalised for malignant neoplasm of rectum in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 30% of hospital consultant episodes for malignant neoplasm of rectum occurred in 15-59 year olds in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 23% of hospital consultant episodes for malignant neoplasm of rectum occurred in people over 75 in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 65% of hospital consultant episodes for malignant neoplasm of rectum were single day episodes in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • % (175,563) of hospital bed days were for malignant neoplasm of rectum in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 0.37% (46,755) of hospital consultant episodes were for benign neoplasm of colon, rectum, anus and anal canal in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 95% of hospital consultant episodes for benign neoplasm of colon, rectum, anus and anal canal required hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 56% of hospital consultant episodes for benign neoplasm of colon, rectum, anus and anal canal were for men in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 44% of hospital consultant episodes for benign neoplasm of colon, rectum, anus and anal canal were for women in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 2% of hospital consultant episodes for benign neoplasm of colon, rectum, anus and anal canal required emergency hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 6.2 days was the mean length of stay in hospitals for benign neoplasm of colon, rectum, anus and anal canal in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 2 days was the median length of stay in hospitals for benign neoplasm of colon, rectum, anus and anal canal in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 64 was the mean age of patients hospitalised for benign neoplasm of colon, rectum, anus and anal canal in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 34% of hospital consultant episodes for benign neoplasm of colon, rectum, anus and anal canal occurred in 15-59 year olds in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 25% of hospital consultant episodes for benign neoplasm of colon, rectum, anus and anal canal occurred in people over 75 in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 81% of hospital consultant episodes for benign neoplasm of colon, rectum, anus and anal canal were single day episodes in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 0.076% (39,731) of hospital bed days were for benign neoplasm of colon, rectum, anus and anal canal in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)

About statistics:

This page presents a variety of statistics about Colorectal cancer. The term 'prevalence' of Colorectal cancer usually refers to the estimated population of people who are managing Colorectal cancer at any given time. The term 'incidence' of Colorectal cancer refers to the annual diagnosis rate, or the number of new cases of Colorectal cancer diagnosed each year. Hence, these two statistics types can differ: a short-lived disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics.



Footnotes: 1. SEER Cancer Statistics Review 1975-2000, National Cancer Institute (NCI)

 

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise